VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
BIOBio-Rad Laboratories, Inc.
$282.44$7.6B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBIODividend History

BIO logoBio-Rad Laboratories, Inc. (BIO) Dividend History

Income profile from 1989 to 2025 with payout safety and yield-on-cost trend

Trailing Dividend / Share
$0.00
0 payments in last 12 months
Dividend Yield
N/A
Current annualized yield
Payout Ratio
N/A
Unknown
Dividend Streak
0 years
Consecutive annual increases
5Y Dividend CAGRN/A
Current Yield on CostN/A
Yield on Cost Trendunknown

BIO Dividend Income Check

Safety

Payout ratio data not available yet.

Consistency

0 straight years of dividend increases.

Income Trend

Yield on cost trend needs more history.

BIO Dividend Scorecard

Yield & Income

Dividend YieldN/A
Trailing DPS$0.00
FrequencyN/A
Payments / 12M0

Payout Safety

Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score5/9

Growth

Growth Streak0 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown

Total Returns

Buyback Yield3.9%
Total Shareholder Yield3.9%
1Y Total Return21.7%
5Y Total Return-54.6%
Estimated $10K growth (return + dividends):
5Y ago$4,53510Y ago$19,76220Y ago$43,121

Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.

BIO Dividend History

No dividend payment history available

This company has not paid dividends during the available data period.

Get BIO's next ex-dividend date and payout in your inbox

Monthly dividend calendar — upcoming ex-dates for stocks you follow.

Free. Unsubscribe any time.

Dividend Analysis

Payout Safety

Bio-Rad Laboratories, Inc. has limited earnings payout data (Unknown).

Piotroski F-Score: 5/9 — moderate financial health.

Growth Track Record

BIO does not have a current streak of consecutive dividend increases.

Total Shareholder Returns

Beyond cash dividends, BIO returns capital through share repurchases. The combined picture: 3.9% buyback yield, 3.9% total shareholder yield.

Income Trend & Total Return

The 5-year total return is -54.6%.

DRIP Growth

A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $19,762 today.

BIO Dividend vs Peers

Comparable companies in the same industry

Div Yield
—
—
Safety
Unknown
— payout
Streak
0Y
— 5Y CAGR
Total Shareholder
3.9%
#2 of 5
CompanyMkt CapYieldPayoutFCF PayoutStreak5Y GrowthBuybackTSY1Y ReturnSafety
BIO logoBIOBio-Rad Laboratories…
$7.6B———0—3.9%3.9%21.7%Unknown
3rd
TMO logoTMOThermo Fisher Scient…
$172.7B0.4%9.4%10.0%814.3%1.7%2.1%18.8%Sustainable
2nd
DHR logoDHRDanaher Corporation
$125.4B0.7%24.3%16.6%914.9%2.5%3.2%-8.2%Sustainable
BRKR logoBRKRBruker Corporation
$8.7B0.3%—52.8%04.6%0.1%0.4%49.3%Unknown
1st
QGEN logoQGENQiagen N.V.
$7.6B0.7%12.8%11.9%0—4.0%4.7%-15.2%Sustainable

BIO Annual Dividend History (1989–2025)

37 years of dividend data

GrowthDecline
YearDPSYoYPmtsEPSPayoutCoverageFCF/ShareFCF PayoutBuyback YldTotal Shld YldYOC
2025$0.00—0$27.87——$13.73—3.6%3.6%—
2024$0.00—0$-65.36——$9.44—2.2%2.2%—
2023$0.00—0$-21.82——$7.47—4.5%4.5%—
2022$0.00—0$-121.79——$2.70—1.7%1.7%—
2021$0.00—0$140.83——$17.73—0.2%0.2%—
2020$0.00—0$126.20——$15.80—0.6%0.6%—
2019$0.00—0$58.27——$11.91—0.3%0.3%—
2018$0.00—0$11.94——$5.15—0.7%0.7%—
2017$0.00—0$4.07——$-0.37—0.0%0.0%—
2016$0.00—0$0.88——$2.51—0.0%0.0%—
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

37+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

BIO — Frequently Asked Questions

Quick answers to the most common questions about buying BIO stock.

How much dividend does BIO pay per share?

Bio-Rad Laboratories, Inc. (BIO) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.

When is BIO's next ex-dividend date?

BIO's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. BIO typically pays dividends quarterly.

Is BIO's dividend safe?

BIO's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.

How many years has BIO increased its dividend?

BIO has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.

How often does BIO pay dividends?

Bio-Rad Laboratories, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 36+ years from 1989 to 2025.

How much would $10,000 invested in BIO grow with dividend reinvestment?

With dividends reinvested (DRIP), $10,000 invested in BIO five years ago would be worth approximately $4,535 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.

What is BIO's yield on cost for long-term holders?

BIO's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.